Faiz Anwer MD

PubMed

• Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States.
  Sudipto Mukherjee, Weichuan Dong, Aaron T Gerds, Hetty E Carraway, Abhay Singh
  Blood Neoplasia. 2025-11-01
• Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.
  Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi
  British Journal of Haematology. 2025-10-23
• Under the Hood: Evidence-Based Review of Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies.
  Asfand Yar Cheema, Hossam M Ali, Bibi Maryam, Muhammad Faisal Aslam, Praveena S Thiagarajan
  Transplantation and Cellular Therapy. 2025-10-09

Abstracts/Posters

• Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Infections Associated with CAR T Therapy for Treatment of Hematological Malignancies
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Efficacy and Safety of Once Versus Twice Weekly Carfilzomib Based Therapies in Relapsed Refractory Multiple Myeloma- a Systematic Review
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all